IL6 and atherosclerosis: Studies have shown that mutated myeloid cells derived from CHIP clones exhibit a pro-inflammatory phenotype, with enhanced production of interleukin-1β (IL-1β) and interleukin-6 (IL-6), key mediators in the pathogenesis of atherosclerosis and vascular injury.18,19